Riociguat
Back to searchMolecule Structure
Scientific Name
Riociguat
Description of the Drug
Riociguat is a stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08931
http://www.drugbank.ca/drugs/DB08931
Brand Name(s)
Adempas, Bay 63-2521
Company Owner(s)
Bayer Healthcare Pharmaceuticals Inc, Msn Laboratories Private Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Soluble guanylate cyclase | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2111348 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL245457 | |
Human Metabolome Database | HMDB0257236 | |
DrugBank | DB08931 | |
PubChem: Thomson Pharma | 16393220 | |
PubChem | 11304743 | |
LINCS | LSM-45758 | |
Nikkaji | J2.832.869I | |
PDBe | GZO | |
DrugCentral | 4807 | |
Brenda | 11935 | 147765 |
ChemicalBook | CB62473752 | |
Guide to Pharmacology | 5257 | |
rxnorm | RIOCIGUAT | ADEMPAS |
PubChem: Drugs of the Future | 87550988 | |
ChEBI | 76018 | |
ZINC | ZINC000003819392 |